Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,896 | -22,008 | -15,302 | 49,219 | -39,659 |
| Depreciation Amortization | 439 | 808 | 1,148 | 865 | 1,380 |
| Accounts receivable | -1,414 | -1,259 | -51 | 5,459 | -7,125 |
| Other Working Capital | -9,084 | 20,382 | 15,053 | -37,764 | 8,007 |
| Other Operating Activity | 3,782 | 3,915 | 2,503 | -3,118 | 9,697 |
| Operating Cash Flow | $-2,381 | $1,838 | $3,351 | $14,661 | $-27,700 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -179 | -629 | -257 | -156 | -774 |
| Purchase Of Investment | -71,325 | -144,567 | -101,607 | -67,476 | -20,072 |
| Sale Of Investment | 72,016 | 149,322 | 96,741 | 31,646 | 52,610 |
| Investing Cash Flow | $512 | $4,126 | $-5,123 | $-35,986 | $31,764 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 9,400 | N/A | N/A |
| Debt Repayment | -3,843 | -3,312 | N/A | N/A | N/A |
| Common Stock Issued | 1,417 | 2,042 | 441 | 21,125 | 2,944 |
| Other Financing Activity | 0 | 0 | -316 | 0 | 0 |
| Financing Cash Flow | $-2,426 | $-1,270 | $9,525 | $21,125 | $2,944 |
| Beginning Cash Position | 26,821 | 22,127 | 14,374 | 14,574 | 7,566 |
| End Cash Position | 22,526 | 26,821 | 22,127 | 14,374 | 14,574 |
| Net Cash Flow | $-4,295 | $4,694 | $7,753 | $-200 | $7,008 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,381 | 1,838 | 3,351 | 14,661 | -27,700 |
| Capital Expenditure | -179 | -629 | -257 | -156 | -774 |
| Free Cash Flow | -2,560 | 1,209 | 3,094 | 14,505 | -28,474 |